Reliability of electrocardiographic surrogates of left ventricular mass in patients with chronic kidney disease

Journal of Hypertension

Volumn 32, Issue 2, 2014, Pages 439-445

  Cordeiro, Antonio C ^a,b   Lindholm, Bengt ^b   Sousa, Márcio G ^a   Picotti, Juliano C ^a   Nunes, Gabriel J ^a   Santana, Marcus R O ^a   Grimaldi, Waldyr ^a   Amparo, Fernanda C ^a   Amodeo, Celso ^a   Carrero, Juan J ^b  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

albuminuria; cardiovascular disease; left ventricular hypertrophy; uremia

Indexed keywords

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; HYPERVOLEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; QRS COMPLEX; RELIABILITY; SENSITIVITY AND SPECIFICITY;

AGED; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS;

EID: 84892962568     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000026     Document Type: Article

References (39)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32:S112-S119.
2. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47:186-192.
3. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27:347-354.
4. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001; 12:2768-2774.
5. Chen SC, Chang JM, Liu WC, Chen YY, Chen LI, Huang JC, et al. The ratio of observed to predicted left ventricular mass is independently associated with increased cardiovascular events in patients with chronic kidney disease. Hypertens Res 2012; 35:832-838.
6. Barbieri A, Bursi F, Mantovani F, Valenti C, Quaglia M, Berti E, et al. Prognostic impact of left ventricular mass severity according to the classification proposed by the American Society of Echocardiography/European Association of Echocardiography. J Am Soc Echocardiogr 2011; 24:1383-1391.
7. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36:286-290.
8. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardio-myopathy. J Am Soc Nephrol 1995; 5:2024-2031.
9. Kim SJ, Oh HJ, Yoo DE, Shin DH, Lee MJ, Kim HR, et al. Electro-cardiographic left ventricular hypertrophy and outcome in hemodial-ysis patients. PLoS One 2012; 7:e35534.
10. Zoccali C. Left ventricular mass index as an outcome measure in clinical trials in dialysis patients: a word of caution. Am J Nephrol 2011; 33:370-372.
11. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995; 25:417-423.
12. Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 1992; 20:1180-1186.
13. Calderon A, Barrios V, Escobar C, Ferrer E, Barrios S, Gonzalez-Pedel V, et al. Detection of left ventricular hypertrophy by different electro-cardiographic criteria in clinical practice. Findings from the sara study. Clin Exp Hypertens 2010; 32:145-153.
14. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90:1786-1793.
15. Hawkins NM, Wang D, McMurray JJ, Pfeffer MA, Swedberg K, Granger CB, et al. Prevalence and prognostic implications of electrocardio-graphic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart 2007; 93:59-64.
16. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969; 71:89-105.
17. Havranek EP, Froshaug DB, Emserman CD, Hanratty R, Krantz MJ, Masoudi FA, et al. Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity. Am J Med 2008; 121:870-875.
18. Fagard RH, Staessen JA, Thijs L, Celis H, Birkenhager WH, Bulpitt CJ, et al. Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. Hypertension 2004; 44:459-464.
19. Ishikawa J, Ishikawa S, Kabutoya T, Gotoh T, Kayaba K, Schwartz JE, et al. Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population. Hypertension 2009; 53:28-34.
20. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 2004; 292:2343-2349.
21. Agarwal R, Light RP. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease. Clin J Am Soc Nephrol 2011; 6:528-536.
22. Cordeiro AC, Qureshi AR, Lindholm B, Amparo FC, Tito-Paladino-Filho A, Perini M, et al. Visceral fat and coronary artery calcification in patients with chronic kidney disease. Nephrol Dial Transplant 2013; [Epub ahead of print] doi: 10.1093/ndt/gft250.
23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
24. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretationof electrocardiograms: validation with autopsy findings. Circulation 1987; 75:565-572.
25. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37:161-186.
26. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a Branch of The European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
27. Zhou X, Obuchowski N, McClish D. Statistical methods in diagnostic medicine. New York: Wiley-Interscience; 2002.
28. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172; discussion 207-112.
29. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 292:2350-2356.
30. Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993; 87:476-486.
31. Devereux RB, Roman MJ. Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. Hypertens Res 1999; 22:1-9.
32. Velten M, Duerr GD, Pessies T, Schild J, Lohner R, Mersmann J, et al. Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice. Cardiovasc Res 2012; 96:422-432.
33. Honsho S, Nishikawa S, Amano K, Zen K, Adachi Y, Kishita E, et al. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting AKT and JNK pathways. Circ Res 2009; 105: 1149-1158.
34. Nagai T, Anzai T, Kaneko H, Mano Y, Anzai A, Maekawa Y, et al. C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response. Hypertension 2011; 57:208-215.
35. Tripepi G, Mattace-Raso F, Sijbrands E, Witteman J, Rapisarda F, Malatino L, et al. Aging and left ventricular mass and function in people with end-stage renal disease. J Am Geriatr Soc 2011; 59: 1636-1641.
36. Agarwal R, Brim NJ, Mahenthiran J, Andersen MJ, Saha C. Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension 2006; 47:62-68.
37. Esquitin R, Razzouk L, Peterson GE, Wright JT Jr, Phillips RA, De Backer TL, et al. Left ventricular hypertrophy by electrocardiography and echocardiography in the African American study of kidney disease cohort study. J Am Soc Hypertens 2012; 6:193-200.
38. Felix-Redondo FJ, Fernandez-Berges D, Calderon A, Consuegra-San-chez L, Lozano L, Barrios V. Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: Hermex study. J Hypertens 2012; 30:1460-1467.
39. Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echo-cardiographic studies. J Hum Hypertens 2012; 26:343-349.